Page last updated: 2024-09-03

succinylacetoacetate and tiletamine hydrochloride

succinylacetoacetate has been researched along with tiletamine hydrochloride in 1 studies

Compound Research Comparison

Studies
(succinylacetoacetate)
Trials
(succinylacetoacetate)
Recent Studies (post-2010)
(succinylacetoacetate)
Studies
(tiletamine hydrochloride)
Trials
(tiletamine hydrochloride)
Recent Studies (post-2010) (tiletamine hydrochloride)
6002,819121,228

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hjalmarson, O; Holme, E; Lindstedt, S; Lock, EA; Strandvik, B1

Other Studies

1 other study(ies) available for succinylacetoacetate and tiletamine hydrochloride

ArticleYear
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.
    Lancet (London, England), 1992, Oct-03, Volume: 340, Issue:8823

    Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Acetoacetates; alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Child; Child, Preschool; Cyclohexanones; Erythrocytes; Heptanoates; Humans; Hydroxybenzoates; Infant; Kidney Tubules; Liver; Nitrobenzoates; Phenylalanine; Phosphates; Porphobilinogen Synthase; Proteinuria; Tyrosine

1992